FHB
NKTR icon

First Hawaiian Bank’s Nektar Therapeutics NKTR Stock Holding History

First Hawaiian Bank’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed -$7K – 1255
2019
Q1 		$7K Sell
14
-18
-56% -$10.7K ﹤0.01% 1473
2018
Q4 		$16K Sell
32
-50
-61% -$30.2K ﹤0.01% 1344
2018
Q3 		$75K Buy
+82
New +$70K ﹤0.01% 1035

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Hawaiian Bank's NKTR Position: Q2 2019 in Review

First Hawaiian Bank sold out of Nektar Therapeutics (NKTR) in Q2 2019, closing a stake of 14 shares — an estimated $7K sold.

First Hawaiian Bank first reported a position in NKTR in Q3 2018 and held it in 3 quarters. The position peaked at $75K in Q3 2018. 336 funds tracked by Wall St. Rank hold NKTR as of Q2 2019.

  • First Hawaiian Bank reported no remaining Nektar Therapeutics position as of Q2 2019 after selling out during the quarter.
  • First Hawaiian Bank sold 14 Nektar Therapeutics shares in Q2 2019, an estimated $7K.
  • First Hawaiian Bank first reported a position in Nektar Therapeutics in Q3 2018 and held it in 3 quarters.
  • First Hawaiian Bank's Nektar Therapeutics position peaked at $75K in Q3 2018.
  • 336 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.